Yezan Munther Haddadin

Director

Director at Outlook Therapeutics, Inc., filing insider transactions between 2026-05-26 and 2026-06-02.

Total Purchases

$39K

2 transactions

Total Sales

—

0 transactions

Companies Traded

2 total filings

Active Since

2026-05-26

Last: 2026-06-02

Companies

Outlook Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-02	OTLK	Purchase	29.0K	$0.83	$24K	66.2K	SEC ↗
2026-05-26	OTLK	Purchase	34.0K	$0.44	$15K	37.2K	SEC ↗